GovChime
Notice ID: 6ca213a1a12646e58555de00883fd662PresolicitationArchived

Notice of Intent to Sole Source – American Association of Blood Banks for Specialized Blood Products Annual Accreditation Fee

Archived on March 6, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
6:00 AM EST
Posted
February 26, 2026
Notice type
Presolicitation
Set-aside
No Set aside used
NAICS
621991: Blood and Organ Banks
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH - CC
Place of performance
Bethesda, Maryland, 20892
Last updated
Nov 2, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
26-000709
Notice ID
6ca213a1a12646e58555de00883fd662

Description

Notice of Intent to Sole Source – American Association of Blood Banks for Specialized Blood Products Annual Accreditation Fee
Product Service Code: R499
NAICS Code: 621991
Place of Performance: Bethesda, MD 20892
POTS Number: 26-000709

Description

This Notice of Intent is issued for informational purposes only and does not constitute a request for quotations. No solicitation will be issued, and quotations will not be accepted.

The National Institutes of Health (NIH), Office of Purchasing and Contracts, on behalf of the Department of Transfusion Medicine, intends to award a sole source contract to:

American Association of Blood Banks Inc
4550 Montgomery Avenue, Suite 700N
Bethesda, Maryland 20814-3264

The purpose of this acquisition is to cover annual accreditation fees for the Department of Transfusion Medicine’s accreditation assessments. Total costs will vary annually, as fees are determined by the number of accreditation types requested, the annual number of products manufactured, and the range of product types produced.

Pricing listed at this time is a placeholder and will be updated upon receipt of the official invoice to reflect actual costs.

Sole Source Justification

The American Association of Blood Banks Inc is the only known organization authorized to assess compliance with its published standards. Accreditation through AABB is required for member organizations.

Additionally, AABB provides inspection services required by HHS/CMS to obtain and maintain a certificate of compliance necessary to issue clinical test results. The Department of Transfusion Medicine’s TSL and TTV sections perform and report clinical diagnostic tests that must comply with CLIA regulatory requirements.

This procurement is conducted in accordance with FAR Subpart 13.106-1(b)(1), Simplified Acquisition Procedures, which permits sole source awards when only one source is reasonably available due to unique requirements.

Submission Instructions

Interested vendors who believe they can provide equivalent accreditation and inspection services may submit a capability statement for consideration. The Government will review all submissions to determine whether a competitive acquisition is warranted. The decision to compete this requirement remains solely at the Government’s discretion.

Responses Due

March 5, 2026, at 6:00 AM EST

Submit responses via email to:
Shasheshe Goolsby
Team Lead
Email: shasheshe.goolsby@nih.gov

Please reference POTS Number 26-000709 in all correspondence.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

  1. 3
    Version 3PresolicitationArchivedCurrent

    Notice of Intent to Sole Source – American Association of Blood Banks for Specialized Blood Products Annual Accreditation Fee

    Notice 6ca213a1a12646e58555de00883fd662 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
Request for Information: Federal Occupational Health (FOH) National Staffing Support Services I. Introductory This is a Request for Information (RFI). This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this Request for Information is to obtain knowledge and information on potential vendor interest for project planning purposes. II. Project Description A. Background: FOH provides defined health services as well as consultation to Federal customer agencies exclusively through Interagency Agreements (IAAs). FOH is a leading provider of occupational health services (OHS) within the Federal Government, delivering services to numerous federal agencies and supporting a large federal workforce. Services are provided when FOH enters into agreements that are negotiated with federal departments and federal agencies’ national headquarters, and/or with their regional/local components for products ranging from a standard package of OHS program components to an array of services, including clinical services delivery, expert medical consultation tailored to a particular federal agency’s OHS needs, wellness and health promotion, behavioral health services as well as organizational development related issues. FOH maintains sole responsibility for consulting with its federal customer partners. The Vendor’s main responsibility is to provide Contractors who deliver FOH services as outlined in the Performance Work Statement (PWS). FOH defines OHS as the seamless coordination of comprehensive services using a data-driven approach to assist agencies in achieving a culture of health and high performance. FOH comprehensive services include: Clinical Health Services (CHS) - Occupational medicine services, including urgent medical care, medical examination, employability consulting, and case review services that focus on assessing the medical ability of employees to perform their essential job duties safely, reducing lost workdays, and increasing employee productivity, as well as fitness for duty services that focus on the assessment of the ability of the employee to meet immediate job demands, increase employee productivity and improve employee performance. Environmental Health and Safety Services (EHSS) - Services to ensure a safe working environment through site assessments, environmental health oversight of all FOH occupied spaces, emergency preparedness and emergency response. Wellness and Health Promotion Services (WHPS) - Services to assist employees in achieving and maintaining good health so that they can sustain peak performance through fitness classes and wellness programs. Behavioral Health Services (BHS) – Employee Assistance Program (EAP), Work/Life and other behavioral health services designed to promote emotional well-being and a healthy life balance through stress management, financial legal counseling and professional referral. Operations and Management (O&M) – Services supporting FOH operations, management, and associated service areas. FOH services are designed to improve health outcomes and employee productivity, while reducing occupational health risks, absenteeism and overall employee health care costs. FOH’s mission is to be the occupational health provider of choice for the federal government.FOH staff plays a critical role in ensuring FOH maintains its status as the premier consultant provider of integrated OHS to federal agencies and their employees. By offering flexible, cost competitive solutions, FOH sets the standard for a culture of health and safety across the federal workforce. The Vendor is required to provide Contractor support for all occupational health services that FOH provides, including health promotion activities, data collection, and Agency/FOH initiatives requiring collaboration. Contractors are responsible for supporting FOH in the provision of occupational health services across the multiple services areas including but not limited to, account management, customer service, business operations, clinical health services, quality assurance, and case management. Contractors may also be responsible for supporting direct patient care, including providing safe, high-quality occupational health services, delivering health education, and raising awareness of key health indicators, associated risks to optimal health, and effective strategies for maintaining optimal health. FOH achieves these goals through services, including, but not limited to: a) Onsite clinical services b) Account management c) Financial analysis and cost estimation d) Billing and cost recovery e) Medical evaluations and clearances f) Quality analysis and review g) Complaint management h) Agreement management i) Specialized health services j) Consulting The quality of clinical services and strength of program effectiveness depend heavily on the expertise and experience of the Contractors. Contractors are expected to provide competent services to assist in the management of accounts and support client and organizational needs effectively. Contractors involved in providing specialized health services and medical case reviews must maintain the required credentials, licensure, and certifications appropriate to their role and per FOH’s requirements. Contractor participation in professional associations and pursuit of additional certifications and specialized training is strongly encouraged to keep current with identified best practices and medical advancements. Contractor promotion of such participation and pursuits is expected. Although required, pursuit of professional certifications, associations, and training is at the risk of Vendors. FOH will not be responsible for reimbursement. SPSs include FOH Occupational Health Centers, FOH Area Offices, and remote sites throughout the contract area. Services provided under this contract shall primarily be performed at the location identified in the Work Plan or otherwise specified by the COR (Attachment TBD). Purpose and Objectives: A. The primary purpose of this contract is to provide Contractor staffing services that do not involve direct care within Occupational Health Centers (OHCs). Direct care services within OHCs are considered secondary and are not guaranteed under this contract. To meet its mission, the scope of this contract shall cover FOH’s contract service requirements including, but not limited to, business operations, administrative, consultation, and delivery of occupational health support and direct services within the Continental United States (CONUS), and Outside the Continental United States (OCONUS). If within its Congressional authority, it is imperative that FOH acts quickly and maintains sufficient flexibility to meet the need, wherever the need arises. B. Project Requirements: Refer to the attached Performance Work Statement (PWS) C. Anticipated Period of Performance: The anticipated award date is June 30, 2027. The anticipated period of performance is five (5) years from award including a twelve (12) month base period with four (4) 12-month option periods. D. Capability Statement /Information Sought: Interested companies shall provide details of up to three (3) similar projects completed within the past three (3) years, including the following information: 1. Customer Name 2. Customer Point of Contact (POC) information/Client Email 3. Total Contract Value 4. Period of Performance 5. Brief Description of Services Provided 6. Is there a CPARS available, yes or no? E. Information Submission Instructions: Interested companies should: 1. Review all attachments included with this RFI notice 2. Submit a response that includes: o Feedback on the attachments (if any) o Complete answers to all questions in the attached "RFI Questions – Federal Occupational Health (FOH) National Staffing Support Services” document. o Complete answers to all items listed under "Capability Statement/Request for Information” Capability statements and responses shall be submitted via email to Tyra.Turner@hhs.gov and Lynn.Tantardini@hhs.gov no later than November 16, 2026, at 2pm EST. The subject line for the email heading shall be “Federal Occupational Health (FOH) National Staffing Support Services– 7571MN27R00010” Please provide succinct detail and depth to enable Government review and assessment. Please limit responses to ten (10) pages (8 ½ x 11, single-spaced, Times New Roman, 12-point font, ¾ inch margins). Please add a cover letter to your response with the following information: 1. Company Name 2. Company mailing address, telephone number and website address 3. Company Unique Entity ID number 4. Company points(s) of contact name and email address 5. Business Size relative to NAICS code 6. Any Governmentwide Acquisition Contract (GWAC), General Services Administration (GSA) Schedule vehicle, or other available procurement vehicle your company maintains that could meet this requirement. 7. Type of Company (e.g., large business, small business, 8(a), woman owned, veteran owned, etc.) as registered in the System for Award Management (SAM). 8. Identify any/all teaming arrangements III. Disclaimer and Important Notes: This notice does not oblige the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by the respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed. Information provided will be used to assess tradeoffs and alternatives available for the potential requirement and may lead to the development of solicitation. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Any solicitation resulting from the analysis of information obtained will be announced to the public in SAM in accordance with FAR Part 5. However, responses to this notice will not be considered adequate to responses to solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
-Special Notice11/16/2026
-AwardedOpen
The requirement to conduct pre-employment civilian drug testing was placed on the Department of War (DoW) agencies and Military Services, which, in turn, developed separate programs governed by separate DoW Directives. In an effort to meet the need to conduct drug testing under HHS guidelines, the Department of Interior ( established a drug testing services contract through its National Business Center. Subsequent contracts have been used to facilitate the specimen collection and medical review services, while laboratory analysis was conducted at a DoW laboratory certified by HHS.
-Market Research11/01/2026
This is not a solicitation announcement. This is a Sources Sought Notice (SSN) only. This SSN is issued solely for market research and planning purposes – it does not constitute a Request for Quotation (RFQ) or a promise to issue an RFQ in the future. Further, the SSN does not commit the Government to contract for any supply or service whatsoever. The FDA is not seeking proposals and will not accept any unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this SSN; all costs associated with responding to this SSN will be solely at the expense of the interested respondents. Not responding to this SSN does not preclude participation in any future RFQ, if issued. The purpose of this SSN is to gain knowledge of potential qualified vendors, including large business sources, small business sources and their size classifications (i.e., HUBZone 8(a), 8(a), HUBZone, Service-Disabled Veteran-Owned, Veteran-Owned, Women-Owned Small Business, and Small Disadvantaged Business) relative to the North American Industry Classification System (NAICS) code. Responses to this SSN will be used by the Government to make appropriate determinations about potential sources. Project Title: FDA/CDRH Scientific Technical Capacity for Regulatory Review Background: To assist the U.S. Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH) in fulfilling its mission, CDRH seeks expert consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle. CDRH requires consultants that have skilled experience to assist with medical device regulatory review work and supporting scientific activities, such as research, cybersecurity and digital health consultations, regulatory consultations and auditing, and interacting with industry and patients. The CDRH requires consultants that have sufficient skilled capacity in many science, engineering, and clinical specialties, including Anesthesiology, Biology, Biomedical Engineering, Chemistry, Clinical laboratory testing, Computer Science and Engineering, Consumer Safety, Cybersecurity, Data Science, Dentistry, Digital Health, Epidemiology, Gastroenterology, General Engineering, Health Science, Infectious Diseases, Interdisciplinary Engineer/Scientist, Molecular testing, Neurology, Optics, Patient Engagement, Physics, Psychiatry, Public Health, Pulmonology, Reprocessing medical devices, Social Scientist, Software Engineering, Statistics and Biostatistics, Sterilization, Toxicology, Urology, Veterinary Medicine, and Virology. Objective: The primary objective of this effort is to provide the CDRH with a vehicle to acquire the support services of advanced professional and scientific consultants to assist CDRH’s Offices with regulatory review across the total product lifecycle, including the supporting scientific, engineering, clinical, and regulatory activities. The services provided will be critical scientific expertise and capacity in support for the evaluation of the continued performance, safety, and effectiveness, with respect to devices approved, cleared, licensed, or authorized for use for the treatment, prevention, or diagnosis of medical conditions by the FDA. Instructions for Responses to this SSN: Your responses to the questions provided below will assist the Government in selecting the appropriate acquisition method. Page limit: Maximum 15 pages (font size Times New Roman 11 or larger). In addition to responses to the below questions, each vendor responding to this SSN shall also fill out and provide responses to “Attachment B-Vendor Feedback Form.” The Vendor Feedback Form is not included in the 15-page limit. A copy of the company capability statement will also be accepted (but not in place of the responses to the below questions or the Vendor Feedback Form). The anticipated period of performance consists of one (1) Base Year and four (4) Option Years. Responses to this SSN must include company name, address, point of contact, size of business pursuant to the NAICS code, and must respond to the following questions: Is your business a small business under the NAICS code? Does your firm qualify as a Small Disadvantaged Business? If disadvantaged, specify if your firm is certified under Section 8(a) of the Small Business Act? Are you considered a certified HUBZone firm? Are you considered Woman-Owned or operated business? Are you a certified Service-Disabled Veteran-Owned or Veteran-Owned business? Included is a draft Statement of Work that is inclusive of the anticipated Task Areas (“Attachment A-Draft Statement of Work”). All interested parties can provide written opinions/questions on the draft Statement of Work. All opinions/questions expressed should focus on strengthening the draft Statement of Work Tasks to ensure industry understands and comprehends the government’s requirements. Responses to this SSN shall be submitted via e-mail to Melinda Kim, Contract Specialist, at Melinda.Kim@fda.hhs.gov, (with a CC: to Nicholas Bisher, Contracting Officer, at Nicholas.Bisher@fda.hhs.gov), by 2:00 PM Eastern Standard Time on November 17, 2026. The subject line of the e-mail shall reference, “Vendor Response to SSN 75F40127Q00006.” After a review of the received responses, a formal solicitation may be published on SAM.gov or on GSA eBuy. No solicitation is currently available. This is not a request for quotation and in no way obligates the Government to award any contract. Responses to this SSN will not be considered adequate responses to the solicitation, a request to be added to a prospective offerors list, or a request to receive a copy of the solicitation. Attachments: Attachment A-Draft Statement of Work Attachment B-Vendor Feedback Form
-Market Research11/17/2026
The Department of Veterans Affairs, Network Contracting Office 17, intends to award a Firm-Fixed price, single-award IDIQ to Carter Bloodcare, for procurement of the following Blood and Blood Products (“X” represents Ordering Periods 1-5): Item # Description Est Annual Needs Unit X001 *Red Cells, Leukocyte reduced 4056 Unit X002 Platelets, Pheresis, Leukocyte reduced 416 Unit X003 Fresh frozen plasma, OR Plasma frozen <24 hours 350 Unit X004 Cryoprecipitate, frozen pooled from 5 donors 150 Unit X005 Platelet-pheresis, HLA matched 5 Unit X006 Deglycerolyzed Red cells 5 Unit X007 Freezing of Patient RBC 5 Ea X008 Deglycerolization of frozen RBC 5 Ea X009 Irradiation Fee 1000 Ea X010 Class 1 HLA Type 1 Ea X011 HLA Typing; A, B, C, single antigen 1 Ea X012 HLA-A,B, Molecular; Request Coding 1 Ea X013 HLA Computer match fee 10 Ea X014 ABID; PLT Immunoglobulin Assay XM 5 Ea X015 ABID; PLT Immunoglobulin Assay PLA1 1 Ea X016 ABID; Platelet Antibody 3 Ea X017 Washing (red blood cells) 3 Ea X018 Antigen Screen, Tier 1 antigen (C, c, E, or K) 30 Ea X019 Antigen Screen, Tier 2 antigen (Jka, Jkb, Fya, Kpa, e, or P1) 50 Ea X020 Antigen Screen, Tier 3 antigen (Fyb, Kpb, S, s, Cw, k, Wra, or High prevalence) 50 Ea X021 ABO/Rh type 10 Ea X022 Blood Typing-ABO/Rh Discrepancy 2 Ea X023 Antibody Screen, RBC, each Serum Technique 10 Ea X024 Cold Agglutinin, Screen 1 Ea X025 AHG Test; Direct, each antiserum 5 Ea X026 ABID, RBC Antobodies, ea panel 10 Ea X027 Antibody Elution (RBC), each 6 Ea X028 Pretreat RBC with Enzymes, each 3 Ea X029 Pretreat Serum with Absorption x1 2 Ea X030 Pretreat Serum with Absorption x2 2 Ea X031 Pretreat Serum with Absorption x3 2 Ea X032 Drug Studies Request Coding 1 Ea X033 Lectin Panel (Polyagglutination) 1 Ea X034 CMV Negative 3 Ea X035 HgB S Negative 5 Ea X036 Frozen Blood Storage (up to 90 days) 3 Ea X037 Imported Rare Unit Fee 5 Ea X038 Molecular RBC Genotype 20 Ea X039 RHD Molecular Testing 5 Ea X040 RhCE Molecular Testing 5 Ea X041 Molecular Sequencing 1 Ea X042 STAT Reference Testing Fee 30 Ea X043 Sample Pick-Up, Time Sensitive 10 Ea X044 Sample Pick Up – Zone 2 30 Ea X045 Therapeutic Phlebotomy Donation 100 Ea The Dallas Veteran Affairs Health Care Center has a requirement for the supply and delivery of blood and blood products supporting the North Texas Veterans Health Care System (VANTHCS). Contractor will furnish all personnel, labor, transportation, equipment, materials and supplies necessary to provide Human Blood and Blood Products and guidance in Clinical Pathology Procedures as specified herein for eligible VA beneficiaries of the North Texas Veterans Health Care System, VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal, or quotation, by email, to the point of contact and referencing the notice ID 36C25727Q0055, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 21 days from the publication of this notice, a contract/order will be issued to Carter Bloodcare, without any further notice. The proposed contract action is for supplies for which the Government intends to negotiate with only one source. The statutory authority permitting other than full and open competition is 41 U.S.C. § 3304(a)(1), as implemented by FAR 6.103-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The proposed sole source procurement will be made by a pricing agreement with Carter Bloodcare. See attached document: Statement of Work - Blood and Blood Products for North Texas VA.
-Special Notice11/13/2026

Additional Details

Solicitation Number

26-000709

Archive Date

Mar 6, 2026

Office Address

BETHESDA, MD, 20892